About 300 reports

HER2-Positive Breast Cancer - Epidemiology Forecast to 2030 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide, accounting for 25.2% of all incident cases of female cancers, making the disease exceedingly prevalent. Breast cancer is classified...

  • Breast Cancer
  • Epidemiology
  • United States
  • United Kingdom
  • World
  • Cancer Incidence
  • Overweight Prevalence

Breast Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis Global Breast Cancer Screening Market will surpass US$ 52.82 Billion by 2027. Worldwide, breast cancer is one of the most common types of cancer and a significant cause of mortality...

  • Breast Cancer
  • World
  • Breast Screening Coverage
  • Cause-Specific Mortality Rate

Major players in the breast cancer drugs market are F.Hoffmann-La Roche Ltd, Novartis AG, AstraZeneca, Eli Lilly and Company, Celgene Corporation, Biocon, Merck & Co. Inc., Genzyme Corporation, Janssen Global services LLC and MacroGenics Inc. The global breast cancer drugs market is expected to grow from $28.45 billion in 2021...

  • Breast Cancer
  • World

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to grow from $15.37 billion in 2021 to $16.67 billion in...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Oncology Drug Sales
  • Cancer Mortality

The breast lesion localization market is expected to reach USD 305 million by 2026 from USD 244 million in 2021.The growth of this market is mainly attributed to the growing incidence of breast cancer, the increasing rate of the geriatric population (as age contributes to the risk of breast cancer and the rising awareness on the early detection...

  • Breast Cancer
  • Nuclear Imaging Equipment
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Breast Screening Coverage

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates...

  • Breast Cancer
  • Hospital
  • Diagnostics
  • World
  • Breast Screening Coverage

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to grow from $12.67 billion in 2020 to $13.76 billion in...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Oncology Drug Sales
  • Cancer Mortality

Breast Cancer Liquid Biopsy market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Breast Cancer Liquid Biopsy Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Breast Cancer Liquid Biopsy types, applications....

  • Genetic Testing
  • Breast Cancer
  • World

Breast Cancer Screening Test market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Breast Cancer Screening Test Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Breast Cancer Screening Test types, applications....

  • Breast Cancer
  • World

HER-2 Negative Breast Cancer market is one of the high-growth prospect industries with potential opportunities throughout 2028. The HER-2 Negative Breast Cancer Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by HER-2 Negative Breast Cancer types, applications....

  • Breast Cancer
  • World

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Cyclin Dependent Kinase 4 - Drugs In Development,...

  • Breast Cancer
  • Therapy
  • Pharmaceutical
  • World
  • Drug Approval
  • Health Provider Density

Global Breast Cancer Liquid Biopsy Market 2022-2026 The analyst has been monitoring the breast cancer liquid biopsy market and it is poised to grow by $ 464.12 mn during 2022-2026, accelerating at a CAGR of 16.35% during the forecast period. Our report on the breast cancer liquid biopsy market provides a holistic analysis,...

  • Breast Cancer
  • Genetic Testing
  • World

Major players in the breast cancer drugs market are F. Hoffmann-La Roche Ltd, Novartis AG, AstraZeneca, Eli Lilly and Company, and Celgene Corporation. The global breast cancer drugs market is expected to grow from $14.25 billion in 2020 to $14.82 billion in 2021 at a compound annual growth rate (CAGR) of 4%. The growth is mainly due...

  • Breast Cancer
  • World

Major players in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V, Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, and C. R. Bard Inc. The global breast cancer diagnostics market is expected to...

  • Breast Cancer
  • World
  • United States
  • APAC
  • Cancer Mortality
  • Mortality Rate

The Europe breast cancer screening market was valued at US$ 1,231.82 million in 2019 and is projected to reach US$ 1,586.46 million by 2027; it is expected to grow at CAGR of 4.3% from 2020 to 2027. Increasing incidence of breast cancerand presence of prominent players in the breast cancer screening market, as well as robust research and development...

  • Breast Cancer
  • Europe
  • Breast Screening Coverage
  • Drug Approval

The Asia Pacific breast cancer screening was valued at US$ 798.57 million in 2019 and is projected to reach US$ 1,120.77 million by 2027; it is expected to grow at CAGR of 5.4% from 2020 to 2027. Driving factors such as, increasing investments for research in breast cancer management and growing breast cancer prevalence across Asia Pacific...

  • Breast Cancer
  • APAC
  • Breast Screening Coverage
  • Cause-Specific Mortality Rate

Breast Cancer Liquid Biopsy Market by Product & Service (Reagent Kits, Instruments, and Services), Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, and Circulating Tumor DNA), and Application (Diagnostics, Prognostics, and Risk Assessment): Global Opportunity Analysis and Industry Forecast, 2019–2027 The...

  • Genetic Testing
  • Breast Cancer
  • World
  • APAC

Breast Cancer Liquid Biopsy Market Report Overview Breast Cancer Liquid Biopsy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Breast Cancer Liquid Biopsy market types and applications. It is a focused study on Breast Cancer Liquid...

  • Genetic Testing
  • Breast Cancer
  • World
  • APAC
  • Health Provider Density

Breast Cancer Screening Test Market Report Overview Breast Cancer Screening Test market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Breast Cancer Screening Test market types and applications. It is a focused study on Breast Cancer Screening...

  • Breast Cancer
  • World
  • Health Provider Density

HER-2 Negative Breast Cancer Market Report Overview HER-2 Negative Breast Cancer market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across HER-2 Negative Breast Cancer market types and applications. It is a focused study on HER-2 Negative Breast...

  • Breast Cancer
  • World
  • Health Provider Density

Abstract: - Global Breast Cancer Therapeutics Market to Reach $29.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Breast Cancer Therapeutics estimated at US$17.2 Billion in the year 2020, is projected to reach a revised size of US$29.8 Billion by 2027, growing at a CAGR of 8.2% over the analysis...

  • Breast Cancer
  • Therapy
  • World
  • China
  • United States

Abstract: - Global Breast Cancer Screening Market to Reach $22 Billion by 2027 - Amid the COVID-19 crisis, the global market for Breast Cancer Screening estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$22 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027....

  • Hospital
  • Diagnostics
  • Breast Cancer
  • World
  • China
  • United States
  • Breast Screening Coverage

The North America breast cancer screening was valued at US$ 2,064.26 million in 2019 and is projected to reach US$ 2,832.04 million by 2027; it is expected to grow at CAGR of 5.1% from 2020 to 2027. The growing prevalence of breast cancer, and the increasing number of investments and initiatives for breast cancer management are among...

  • Breast Cancer
  • North America
  • United States
  • Breast Screening Coverage
  • Cervical Cancer Screening Coverage

Abstract: - Global Microwave Ablation Market to Reach $286.8 Million by 2027 - Amid the COVID-19 crisis, the global market for Microwave Ablation estimated at US$132.8 Million in the year 2020, is projected to reach a revised size of US$286.8 Million by 2027, growing at a CAGR of 11.6% over the analysis period 2020-2027....

  • Lung Cancer
  • Breast Cancer
  • Liver Cancer
  • World
  • China
  • United States

Abstract: - Global Breast Cancer Liquid Biopsy Market to Reach $936.3 Million by 2027 - Amid the COVID-19 crisis, the global market for Breast Cancer Liquid Biopsy estimated at US$262.6 Million in the year 2020, is projected to reach a revised size of US$936.3 Million by 2027, growing at a CAGR of 19.9% over the analysis...

  • Genetic Testing
  • Breast Cancer
  • World
  • China
  • United States

Abstract: - Global Interventional Oncology Devices Market to Reach $3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Interventional Oncology Devices estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3 Billion by 2027, growing at a CAGR of 5.7% over the analysis...

  • Liver Cancer
  • Lung Cancer
  • Breast Cancer
  • World
  • China
  • United States

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to decline from $13.57 billion in 2019 to $12.60 billion...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Cancer Mortality
  • Oncology Drug Sales

"US Breast Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • US Breast Cancer Drug Market: > USD 20 Billion Opportunity by 2026 • US Breast Cancer clinical Trials: 350 Drugs in Pipeline • More Than 130 Drugs in Phase II & Higher Phases of Trials • Detailed...

  • Breast Cancer
  • United States
  • Drug Approval

Major players in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, and C. R. Bard Inc. The global breast cancer diagnostics market is expected to...

  • Breast Cancer
  • United States
  • World
  • Cancer Mortality
  • Mortality Rate

Global Next-Generation Breast Cancer Diagnostics and Screening Market to Reach $10.48 Billion by 2030 Market Report Coverage - Next Generation Breast Cancer Diagnostic and Screening Market Segmentation • Product Type - BRCA tests, ER/PR tests, HER2 tests • Technology- Real-Time Polymerase...

  • Breast Cancer
  • Diagnostics
  • World
  • Breast Screening Coverage
  • Health Expenditure